Science & Research

Tonix Pharmaceuticals to Showcase Rheumatologic Research at EULAR 2025

Tonix Pharmaceuticals to Showcase Rheumatologic Research at EULAR 2025

Tonix Pharmaceuticals Holding Corp. is set to present its latest research at the Annual European Congress of Rheumatology (EULAR) 2025, highlighting advancements in rheumatologic conditions and its broader pipeline.

June 5, 2025
Triad RF Systems Unveils TA1165 Amplifier for Enhanced CubeSat Communications

Triad RF Systems Unveils TA1165 Amplifier for Enhanced CubeSat Communications

Triad RF Systems introduces the TA1165 solid-state power amplifier, designed to improve X-Band downlink capabilities for CubeSat and SmallSat missions, marking a significant advancement in satellite communication technology.

June 5, 2025
Cure Alzheimer’s Fund Strengthens Leadership with New Board Appointments

Cure Alzheimer’s Fund Strengthens Leadership with New Board Appointments

Cure Alzheimer’s Fund enhances its leadership team by appointing Christine Villas-Boas and Brittany Bowlen to its Board of Directors, aiming to accelerate research against Alzheimer’s disease.

June 4, 2025
Kairos Pharma Ltd. Showcases Promising Preclinical Results for KROS101 at ASCO 2025

Kairos Pharma Ltd. Showcases Promising Preclinical Results for KROS101 at ASCO 2025

Kairos Pharma Ltd. reveals preclinical data at ASCO 2025 indicating KROS101's potential to enhance cancer immunotherapy by improving T cell activity and reducing immune suppression.

June 4, 2025
Study Highlights Delayed Cancer Diagnosis in Younger Populations

Study Highlights Delayed Cancer Diagnosis in Younger Populations

Research from the University of Nottingham shows younger individuals with certain cancers face longer diagnosis times, underscoring the need for improved detection and treatment strategies.

June 4, 2025
ProtoSpace Mfg Partners with IREC 2025 to Foster Aerospace Innovation

ProtoSpace Mfg Partners with IREC 2025 to Foster Aerospace Innovation

ProtoSpace Mfg's sponsorship and participation in the International Rocket Engineering Competition (IREC) 2025 highlights its commitment to advancing aerospace education and innovation, offering students unparalleled opportunities to showcase their engineering skills.

June 4, 2025
Bio-Path Holdings Advances in RNAi Therapeutics with Promising Clinical Trials

Bio-Path Holdings Advances in RNAi Therapeutics with Promising Clinical Trials

Bio-Path Holdings, Inc. makes strides in RNA interference therapeutics, with its DNAbilize® platform showing potential in treating cancers, obesity, and type 2 diabetes, marking a significant step forward in biotechnology.

June 4, 2025
NanoViricides Advances Measles Drug Program as Global Outbreaks Rise

NanoViricides Advances Measles Drug Program as Global Outbreaks Rise

NanoViricides, Inc. has begun animal trials for its antiviral candidate NV-387, targeting measles amidst increasing global outbreaks and vaccine challenges, highlighting a critical step towards addressing a significant public health gap.

June 4, 2025
Understanding Pediatric Growth Hormone Deficiency: Impacts and Advances in Treatment

Understanding Pediatric Growth Hormone Deficiency: Impacts and Advances in Treatment

Pediatric Growth Hormone Deficiency (PGHD) affects 1 in 4,000-10,000 children, influencing their growth, development, and overall health, with early diagnosis and treatment offering a path to improved outcomes.

June 4, 2025
Soligenix Inc. (SNGX) Reports Promising HyBryte Results for CTCL Treatment

Soligenix Inc. (SNGX) Reports Promising HyBryte Results for CTCL Treatment

Interim data from a Soligenix Inc. study highlights HyBryte's potential as a safer, faster-acting treatment for cutaneous T-cell lymphoma, offering new hope for patients with this chronic condition.

June 4, 2025
GeoVax to Present COVID-19 Vaccine Breakthroughs at Keystone Symposia

GeoVax to Present COVID-19 Vaccine Breakthroughs at Keystone Symposia

GeoVax Labs, Inc. will showcase data from two key studies at the Keystone Symposia, highlighting the cross-reactivity and broad-spectrum immunity of its COVID-19 vaccine candidates, marking a significant step forward in the fight against evolving SARS-CoV-2 variants.

June 4, 2025
Scientific American Names David M. Ewalt as New Editor-in-Chief

Scientific American Names David M. Ewalt as New Editor-in-Chief

David M. Ewalt, a seasoned journalist with a strong background in science and technology reporting, has been appointed as the new Editor-in-Chief of Scientific American, signaling a renewed focus on data-driven journalism and the magazine's legacy of scientific exploration.

June 4, 2025
Q.ANT Unveils Groundbreaking Photonic Computing Technology at ISC 2025

Q.ANT Unveils Groundbreaking Photonic Computing Technology at ISC 2025

Q.ANT introduces its photonic Native Processing Server at ISC 2025, showcasing significant advancements in energy efficiency and computational performance for AI and scientific workloads.

June 4, 2025
Dr. Ana Mafé García Unveils the Holy Grail's Journey Through Technology and History

Dr. Ana Mafé García Unveils the Holy Grail's Journey Through Technology and History

Dr. Ana Mafé García, a leading expert on the Holy Grail, collaborates on an innovative project blending historical research with cutting-edge technology to create an immersive experience of the Grail's journey, highlighting its cultural and educational significance.

June 4, 2025
Beverly DeVore-Wedding Elected President of National Science Teaching Association

Beverly DeVore-Wedding Elected President of National Science Teaching Association

Beverly R. DeVore-Wedding, Ph.D., a seasoned educator and advocate for inclusive science education, has been named the 2025–2026 President of the National Science Teaching Association, marking a significant milestone for science education globally.

June 4, 2025
Lorati Unveils NanoClay Paste: A Natural Revolution in Wound Care

Lorati Unveils NanoClay Paste: A Natural Revolution in Wound Care

Lorati Company Limited introduces NanoClay Paste, a natural, mineral-based treatment offering fast and effective healing for chronic wounds and skin infections, marking a significant advancement in non-invasive medical solutions.

June 3, 2025
D-Wave Quantum Inc. Launches Advantage2 Quantum System, Marking a Significant Leap in Quantum Computing

D-Wave Quantum Inc. Launches Advantage2 Quantum System, Marking a Significant Leap in Quantum Computing

D-Wave Quantum Inc. has announced the commercial availability of its Advantage2 quantum computing system, featuring over 4,400 qubits and significant improvements in performance, targeting real-world applications in optimization, materials simulation, and AI.

June 3, 2025
U.S. Naval Sea Cadets Graduate 473, Shaping Future Leaders Across Industries

U.S. Naval Sea Cadets Graduate 473, Shaping Future Leaders Across Industries

The U.S. Naval Sea Cadet Corps celebrates the graduation of 473 cadets, showcasing the program's role in developing leadership and resilience among young Americans for careers in military, science, engineering, and beyond.

June 3, 2025
Telomir Pharmaceuticals Advances Telomere-Targeting Drug, Seeks Strategic Partnerships

Telomir Pharmaceuticals Advances Telomere-Targeting Drug, Seeks Strategic Partnerships

Telomir Pharmaceuticals is preparing to submit an Investigational New Drug (IND) application for Telomir-1, a potential breakthrough small molecule targeting aging mechanisms, with plans to explore strategic collaborations at the BIO International Convention 2025.

June 2, 2025
ESGold Advances Montauban Gold-Silver Project with Innovative Concentration Tests

ESGold Advances Montauban Gold-Silver Project with Innovative Concentration Tests

ESGold Corp. is conducting final spiral concentration tests at its Montauban project, potentially revolutionizing gold and silver extraction by reducing cyanide use and accelerating production timelines.

June 2, 2025
Molecular 'Velcro' Breakthrough Promises Advanced Drug Delivery and Biosensing Technologies

Molecular 'Velcro' Breakthrough Promises Advanced Drug Delivery and Biosensing Technologies

Researchers introduce a novel supramolecular chemistry concept called controllable ultrahigh-affinity molecular recognition (CUAMR), which offers unprecedented control in molecular interactions with potential transformative applications in biotechnology and medicine.

June 1, 2025
Global Water Ecological Assessments: A Critical Strategy for Environmental Management

Global Water Ecological Assessments: A Critical Strategy for Environmental Management

A new study explores the complexity and importance of water ecological assessments worldwide, highlighting their crucial role in ecosystem management, environmental protection, and sustainable resource utilization across different countries and regions.

June 1, 2025
Researchers Uncover Surprising Flexibility in Key Metabolic Enzyme Complex

Researchers Uncover Surprising Flexibility in Key Metabolic Enzyme Complex

A groundbreaking study reveals the dynamic structure of the pyruvate dehydrogenase complex, showing unprecedented flexibility that challenges previous understanding of cellular energy production. The research provides critical insights into metabolic processes with potential implications for disease treatment.

May 31, 2025
Neuroscientists Develop RADICAL: A Breakthrough Tool for Precise Neural Control

Neuroscientists Develop RADICAL: A Breakthrough Tool for Precise Neural Control

Researchers have engineered a novel chemogenetic tool called RADICAL that enables non-invasive, precise manipulation of brain activity using a synthetic chemical, offering significant potential for neuroscience research and therapeutic interventions.

May 31, 2025
Swedish Study Reveals Potential Neurological Connection Between Autism and Parkinson's Disease

Swedish Study Reveals Potential Neurological Connection Between Autism and Parkinson's Disease

A groundbreaking research from Karolinska Institutet suggests a significant biological link between autism spectrum disorder and Parkinson's disease, potentially opening new avenues for understanding neurodegenerative conditions.

May 30, 2025
Lantern Pharma Shows Promise in Pediatric Brain Cancer Treatment

Lantern Pharma Shows Promise in Pediatric Brain Cancer Treatment

Lantern Pharma's experimental drug LP-184 demonstrates significant potential in treating atypical teratoid rhabdoid tumors (ATRT), a rare and aggressive pediatric brain cancer, with preclinical studies showing remarkable improvements in survival rates.

May 30, 2025
From Moon Missions to Manhattan: The Enduring Legacy of OMEGA's Speedmaster Watch

From Moon Missions to Manhattan: The Enduring Legacy of OMEGA's Speedmaster Watch

Ron Gordon Watch Repair explores the historical significance of the OMEGA Speedmaster, highlighting its critical role in space exploration and continuing relevance in vintage watch collecting and maintenance.

May 30, 2025
Alzamend Neuro Advances Innovative Therapies for Mental Health Disorders

Alzamend Neuro Advances Innovative Therapies for Mental Health Disorders

Alzamend Neuro is developing novel therapeutic approaches for challenging neurological and psychiatric conditions, including Alzheimer's, Bipolar Disorder, Major Depressive Disorder, and PTSD. The company's pioneering treatments aim to improve patient outcomes by addressing current treatment limitations.

May 29, 2025
Telomir Pharmaceuticals Reveals Promising Vision Restoration in Preclinical AMD Study

Telomir Pharmaceuticals Reveals Promising Vision Restoration in Preclinical AMD Study

Telomir Pharmaceuticals has demonstrated its oral therapeutic candidate Telomir-1 can restore vision and reverse retinal degeneration in a zebrafish model of age-related macular degeneration, highlighting potential breakthrough treatment for vision loss.

May 29, 2025
University of Houston Receives $3M Grant to Advance Cancer Immunotherapy Research

University of Houston Receives $3M Grant to Advance Cancer Immunotherapy Research

The Texas Cancer Prevention & Research Institute awarded the University of Houston $3 million to establish a biomarker core, potentially transforming cancer research and patient outcomes through advanced immunotherapy techniques.

May 29, 2025
PreviousPage 26 of 32Next